Review
Sep 2026
Umbilical cord blood-derived CAR-NK cells: an emerging off-the-shelf platform for cancer immunotherapy.
Relapses occurring within 2 to 3 months correlated with loss of detectable CAR-NK cells, highlighting limited in vivo persistence as a principal barrier to durable response.
Kun Lu, Mei-Lian Cai, Jing Li et al.
· International journal of hem... · 0 citations